Task Practice and Spinal Cord Stimulation

Eligibility Criteria

• * 22-70 years of age
• * Non-progressive cervical spinal cord injury
• * Minimum 12 months year post-injury.
• * American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification B, C, or D.
• * Able to take part in upper extremity therapy procedures.
• * GRASSP-Prehension score ≥10.
• * MAS Score ≥3 but \<6 in at least one arm.
• * Can commit to the time required for the study.
• * Stable medication profile for at least 4 weeks prior to enrollment.
• * Able to reduce Baclofen dose to 30 mg or less daily.
• * Capable of providing informed consent.
• * Has any unstable or significant medical condition that is likely to interfere with study procedures like severe neuropathic pain, depression, mood disorders, or other cognitive disorders.
• * Has uncontrolled cardiopulmonary disease or cardiac symptoms.
• * Requires ventilator support.
• * Has been diagnosed with autonomic dysreflexia that is severe, unstable, and uncontrolled.
• * Has an autoimmune etiology of spinal cord dysfunction/injury
• * Previously diagnosed as having transverse myelitis
• * History of additional neurologic diseases such as stroke, multiple sclerosis, traumatic brain injury, epilepsy or history of seizures.
• * Peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)
• * Uncontrolled spasms, which have been unstable over the past three months prior to enrollment and are not expected to change.
• * Received Botulinum toxin injections in their upper extremity, neck, or hand within six months prior to enrollment.
• * Has painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection at the time of enrollment.
• * Breakdown in skin area that will come into contact with electrodes.
• * Presence of syringomyelia as determined by an MRI.
• * Currently undergoing treatment for cancer or has been in remission for less than 2 years.
• * Received stem cell treatment within the past two years prior to enrollment.
• * Has any active implanted medical device.
• * Concurrent participation in another drug or device trial that may interfere with this study.
• * In the opinion of the investigators, the study is not safe or appropriate for the participant.
• * Persons who are unable to consent, pregnant women, and prisoners.